- Drug discovery services
- Our technology
- Your benefits
- Resources & Webinars
- News & Events
- About us
May 14 2021
IMMUNO-ONCOLOGY, TARGETING CD20
INOVOTION has a new in vivo assay for Anti-CD20 therapies and B-Cell targeting.
Our R&D team has recently set up and validated a highly specific new assay based on Rituximab and
Daudi cells on chicken embryos.
This changes the landscape by opening a large range of possibilities for rapidly evaluating anti-CD20
therapies and combinations.
Let’s talk about your projects to see how this new assay will further your R&D !!
Feel free to also contact us directly via our contact page.